Patents by Inventor Winfried Edelmann

Winfried Edelmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell extract promoted cloning
    Patent number: 8609374
    Abstract: Methods are disclosed for assembling a plurality of double-stranded DNA fragments into DNA molecules in a single in vitro recombination reaction comprising contacting the plurality of double-stranded DNA fragments with a bacterial extract derived from a RecA deficient bacterial strain so as to assemble the plurality of DNA fragments into DNA molecules.
    Type: Grant
    Filed: June 19, 2012
    Date of Patent: December 17, 2013
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Winfried Edelmann, Yongwei Zhang
  • CELL EXTRACT PROMOTED CLONING
    Publication number: 20130045508
    Abstract: Methods are disclosed for assembling a plurality of double-stranded DNA fragments into DNA molecules in a single in vitro recombination reaction comprising contacting the plurality of double-stranded DNA fragments with a bacterial extract derived from a RecA deficient bacterial strain so as to assemble the plurality of DNA fragments into DNA molecules.
    Type: Application
    Filed: June 19, 2012
    Publication date: February 21, 2013
    Inventors: Winfried Edelmann, Yongwei Zhang
  • Methods for identifying compounds which modulate the activity of MSH5
    Patent number: 7211375
    Abstract: An animal, e.g., transgenic mouse, in which the MSH5 gene is misexpressed. The animal is useful for screening treatments for a number of conditions. Methods for identifying contraceptive agents are also described.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: May 1, 2007
    Assignees: Dana-Farber Cancer Institute, Inc., Albert Einstein College of Medicine of Yeshiva University
    Inventors: Winfried Edelmann, Richard D. Kolodner, Jeffrey W. Pollard, Raju S. Kucherlapati
  • Methods for modulating the activity of MSH-5
    Publication number: 20050153922
    Abstract: An animal, e.g., transgenic mouse, in which the MSH5 gene is misexpressed. The animal is useful for screening treatments for a number of conditions. Methods for identifying contraceptive agents are also described.
    Type: Application
    Filed: December 1, 2004
    Publication date: July 14, 2005
    Applicants: Albert Einstein College of Medicine of Yeshiva University, Dana-Farber Cancer Institute, Inc.
    Inventors: Winfried Edelmann, Richard Kolodner, Jeffrey Pollard, Raju Kucherlapati
  • Methods for identifying contraceptive compounds
    Patent number: 6794147
    Abstract: An animal, e.g., transgenic mouse, in which the MSH4 gene is misexpressed. The animal is useful for screening treatments for a number of conditions. Methods for identifying contraceptive agents are also described.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: September 21, 2004
    Assignees: Wyeth, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Jeffrey W. Pollard, Winfried Edelmann, Paula E. Cohen, Burkhard Kneitz, Panos Stevis, Raju S. Kucherlapati
  • MSH5 ablated mice and uses therefor
    Patent number: 6444873
    Abstract: An animal, e.g., transgenic mouse, in which the MSH5 gene is misexpressed. The animal is useful for screening treatments for a number of conditions. Methods for identifying contraceptive agents are also described.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: September 3, 2002
    Assignees: Albert Einstein College of Medicine of Yeshiva University, Dana-Farber Cancer Institute, Inc.
    Inventors: Winfried Edelmann, Richard D. Kolodner, Jeffrey W. Pollard, Raju S. Kucherlapati